Investment & Business Report

(as of September 2025)

Section I: Active Holdings – Core Portfolio

(Biotech / Quantum / AI / Robotics / Critical Materials)

This portfolio is tilted toward disruptive frontier technologies and critical materials that support long-term growth themes such as quantum computing, gene editing, rare earths, and semiconductors.

🔹 Flagship Picks

1. IonQ (NASDAQ: IONQ) – Quantum Computing

Profile: Ion-trap quantum systems, expanding into modular networks.
Rationale: Most commercially advanced U.S. quantum pure play, with partnerships across big tech and government.
Risks: Capital-intensive scaling; long commercialization timeline.
Outlook: Positioned as a leader in quantum infrastructure.

2. Beam Therapeutics (NASDAQ: BEAM) – Gene Editing

Profile: Pioneer in base-editing technology, advancing BEAM-302 and rare disease pipeline.
Rationale: Unique IP and strategic partnerships make this one of the most differentiated gene-editing companies.
Risks: Clinical trial outcomes and regulatory approvals remain uncertain.
Outlook: A prime candidate for M&A within the biotech sector.

🔹 Critical Materials / Supply Chain

3. Ucore Rare Metals (TSXV: UCU / OTC: UURAF) – Rare Earths & Processing

Profile: Developer of Bokan-Dotson Ridge deposit and Louisiana SMC processing facility.
Rationale: Positioned as a strategic U.S.-aligned rare earth supplier.
Risks: Project financing and permitting.
Outlook: Beneficiary of North American supply-chain independence initiatives.

4. Critical Metals Corp (NASDAQ: CRML) – REE Consolidator

Profile: Vertically integrated rare earth company with multiple global assets.
Rationale: Emerging consolidator in the REE sector.
Risks: Execution risk in integrating acquisitions.
Outlook: Well-positioned to lead a wave of rare earth consolidation.

5. Avalon Advanced Materials (TSX: AVL / OTC: AVLNF) – Lithium & Rare Earths

Profile: Nechalacho rare earth project and Thunder Bay lithium hydroxide facility.
Rationale: Strong Canadian supply chain positioning.
Risks: Early-stage development risk.
Outlook: Potential M&A target in a consolidating critical minerals market.

🔹 Frontier Tech

6. NVE Corporation (NASDAQ: NVEC) – Spintronics

Profile: Niche player in spintronics sensors and MRAM-related IP.
Rationale: Profitable microcap exposure to energy-efficient computing.
Risks: Illiquidity; small-scale revenue.
Outlook: Valuable if spintronics adoption accelerates.

7. Butterfly Network (NASDAQ: BFLY) – Portable Ultrasound

Profile: Handheld ultrasound devices for point-of-care diagnostics.
Rationale: Large addressable market in healthcare.
Risks: Commercial scaling challenges.
Outlook: Positioned to disrupt traditional imaging models.

8. Cabaletta Bio (NASDAQ: CABA) – Autoimmune Cell Therapy

Profile: T-cell therapies targeting autoimmune diseases.
Rationale: Novel approach in an underpenetrated therapeutic area.
Risks: Clinical-stage volatility.
Outlook: High upside if early trial success continues.

9. Intellia Therapeutics (NASDAQ: NTLA) – CRISPR Gene Editing

Profile: CRISPR/Cas9 therapeutic platform; partnered with Regeneron.
Rationale: Among the most advanced gene-editing players.
Risks: Competitive CRISPR landscape.
Outlook: Positioned for significant upside if clinical results are positive.

🔹 Advanced Chips

10. Micron Technology (NASDAQ: MU) – Semiconductors

Profile: Leading DRAM and NAND supplier, critical to AI data infrastructure.
Rationale: Well-placed in the AI-driven semiconductor cycle.
Risks: Pricing cycles in memory markets.
Outlook: Core enabler of AI growth.

🔹 Additional Holdings (Prior Core)

Rigetti Computing (RGTI) – Early quantum bet.
POET Technologies (POET/POETF) – Photonics for AI/datacenters.
Immix Biopharma (IMMX) – CAR-T therapies.
Aeva Technologies (AEVA) – 4D LiDAR.
Alpha Tau Medical (DRTS) – Alpha particle oncology.
Kraken Robotics (PNG/KRKNF) – Subsea defense robotics.
Recursion Pharmaceuticals (RXRX) – AI drug discovery.
Ambarella (AMBA) – AI vision chips.

Section II: Watchlist – Diversifiers and Balancers

(SaaS, Cybersecurity, Clean Energy, Defense, Industrials)

This group complements frontier holdings with more diversified exposure to enterprise SaaS, clean energy, defense contractors, and industrial conglomerates.

🔹 Neutral Baseline

Tenable (TENB) – Cybersecurity.
Shoals Technologies (SHLS) – Solar/EV infrastructure.
nCino (NCNO) – Cloud banking SaaS.
DoubleVerify (DV) – Digital ad verification.
Matterport (MTTR) – 3D spatial/digital twins.
LiveRamp (RAMP) – Data connectivity & privacy.
Jfrog (FROG) – DevOps infrastructure.
C3.ai (AI) – Enterprise AI.
Hims & Hers (HIMS) – Consumer telehealth.
Toast (TOST) – Restaurant SaaS & payments.

🔹 Additional Watchlist Names

11. Honeywell International (NASDAQ: HON) – Diversified Industrials

Why on Watch: Exposure to aerospace, energy, automation, and quantum R&D.

12. Nokia (NYSE: NOK) – Telecom Networks

Why on Watch: Positioned for 5G/6G infrastructure cycles.

13. Cameco Corp (TSX: CCO / NYSE: CCJ) – Uranium

Why on Watch: Global leader in uranium production, benefitting from nuclear renaissance.

14. Opendoor (NASDAQ: OPEN) – Real Estate Tech

Why on Watch: Online housing platform; speculative recovery play.

15. BWX Technologies (NYSE: BWXT) – Nuclear Defense & SMRs

Why on Watch: Supplies nuclear reactors and defense systems with strong government ties.

📊 Tiered Allocation Model

Tier 1: High-Conviction Core (40–50%)

IonQ (IONQ)
Beam Therapeutics (BEAM)
Ucore Rare Metals (UCU/UURAF)
Critical Metals Corp (CRML)
Micron Technology (MU)
NVE Corporation (NVEC)

Tier 2: Satellite High-Risk (30–35%)

Intellia (NTLA), Cabaletta (CABA), Recursion (RXRX), Immix (IMMX)
Alpha Tau (DRTS), Butterfly Network (BFLY)
Rigetti (RGTI), POET (POET), Aeva (AEVA), Kraken Robotics (PNG/KRKNF)

Tier 3: Stabilizers & Balancers (20–25%)

Honeywell (HON), BWXT (BWXT), Cameco (CCO/CCJ)
Ambarella (AMBA), Tenable (TENB), Shoals (SHLS), nCino (NCNO), DoubleVerify (DV)
Nokia (NOK), Hims & Hers (HIMS), Toast (TOST), Opendoor (OPEN)

⚖️ Strategic Outlook

High-Conviction Core: Anchored in quantum computing, gene editing, semiconductors, and rare earths — sectors with exponential upside.
Satellite High-Risk: Early-stage frontier bets; volatile but capable of outsized gains on breakthroughs.
Stabilizers & Balancers: Defensive industrials, nuclear, cybersecurity, and SaaS — providing diversification, lower volatility, and steady growth.

This allocation creates a barbell structure, with frontier technology on one side and stabilizing industrial/cybersecurity/energy names on the other, designed to balance growth with downside protection.

ED Note:

: I would be remiss if I didn't include ARCT in the possible exponential list!

Friday, September 12, 2025

Stocks I believe may be poised for exponential growth over the next year or so!